Teva's digital health collaboration with rimidi expands to include respiratory monitoring program integration with a large u.s. health system

Parsippany, n.j.--(business wire)--teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries ltd. (nyse and tase: teva), today announced that a respiratory patient monitoring program using data from teva's digihaler system has been implemented within california's desert oasis healthcare (dohc) system.

TEVA Ratings Summary

TEVA Quant Ranking